Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine

Jason M. Williams, W. Anthony Owens, Gregory H. Turner, Christine Saunders, Concetta Dipace, Randy D. Blakely, Charles P France, John C. Gore, Lynette C Daws, Malcolm J. Avison, Aurelio Galli

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

The behavioral effects of psychomotor stimulants such as amphetamine (AMPH) arise from their ability to elicit increases in extracellular dopamine (DA). These AMPH-induced increases are achieved by DA transporter (DAT)-mediated transmitter efflux. Recently, we have shown that AMPH self-administration is reduced in rats that have been depleted of insulin with the diabetogenic agent streptozotocin (STZ). In vitro studies suggest that hypoinsulinemia may regulate the actions of AMPH by inhibiting the insulin downstream effectors phosphotidylinositol 3-kinase (PI3K) and protein kinase B (PKB, or Akt), which we have previously shown are able to fine-tune DAT cell-surface expression. Here, we demonstrate that striatal Akt function, as well as DAT cell-surface expression, are significantly reduced by STZ. In addition, our data show that the release of DA, determined by high-speed chronoamperometry (HSCA) in the striatum, in response to AMPH, is severely impaired in these insulin-deficient rats. Importantly, selective inhibition of PI3K with LY294002 within the striatum results in a profound reduction in the subsequent potential for AMPH to evoke DA efflux. Consistent with our biochemical and in vivo electrochemical data, findings from functional magnetic resonance imaging experiments reveal that the ability of AMPH to elicit positive blood oxygen level-dependent signal changes in the striatum is significantly blunted in STZ-treated rats. Finally, local infusion of insulin into the striatum of STZ-treated animals significantly recovers the ability of AMPH to stimulate DA release as measured by high-speed chronoamperometry. The present studies establish that PI3K signaling regulates the neurochemical actions of AMPH-like psychomotor stimulants. These data suggest that insulin signaling pathways may represent a novel mechanism for regulating DA transmission, one which may be targeted for the treatment of AMPH abuse and potentially other dopaminergic disorders.

Original languageEnglish (US)
Pages (from-to)2369-2378
Number of pages10
JournalPLoS Biology
Volume5
Issue number10
DOIs
StatePublished - Oct 2007

Fingerprint

amphetamine
Amphetamine
dopamine
Dopamine
Streptozocin
streptozotocin
Aptitude
insulin
Insulin
Phosphotransferases
transporters
Rats
Chronoamperometry
phosphotransferases (kinases)
Amphetamine-Related Disorders
rats
Corpus Striatum
Proto-Oncogene Proteins c-akt
Dopamine Plasma Membrane Transport Proteins
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)

Cite this

Williams, J. M., Owens, W. A., Turner, G. H., Saunders, C., Dipace, C., Blakely, R. D., ... Galli, A. (2007). Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biology, 5(10), 2369-2378. https://doi.org/10.1371/journal.pbio.0050274

Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. / Williams, Jason M.; Owens, W. Anthony; Turner, Gregory H.; Saunders, Christine; Dipace, Concetta; Blakely, Randy D.; France, Charles P; Gore, John C.; Daws, Lynette C; Avison, Malcolm J.; Galli, Aurelio.

In: PLoS Biology, Vol. 5, No. 10, 10.2007, p. 2369-2378.

Research output: Contribution to journalArticle

Williams, JM, Owens, WA, Turner, GH, Saunders, C, Dipace, C, Blakely, RD, France, CP, Gore, JC, Daws, LC, Avison, MJ & Galli, A 2007, 'Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine', PLoS Biology, vol. 5, no. 10, pp. 2369-2378. https://doi.org/10.1371/journal.pbio.0050274
Williams JM, Owens WA, Turner GH, Saunders C, Dipace C, Blakely RD et al. Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biology. 2007 Oct;5(10):2369-2378. https://doi.org/10.1371/journal.pbio.0050274
Williams, Jason M. ; Owens, W. Anthony ; Turner, Gregory H. ; Saunders, Christine ; Dipace, Concetta ; Blakely, Randy D. ; France, Charles P ; Gore, John C. ; Daws, Lynette C ; Avison, Malcolm J. ; Galli, Aurelio. / Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. In: PLoS Biology. 2007 ; Vol. 5, No. 10. pp. 2369-2378.
@article{d4f4ff246f8e46d3b99bbe47a1e785c8,
title = "Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine",
abstract = "The behavioral effects of psychomotor stimulants such as amphetamine (AMPH) arise from their ability to elicit increases in extracellular dopamine (DA). These AMPH-induced increases are achieved by DA transporter (DAT)-mediated transmitter efflux. Recently, we have shown that AMPH self-administration is reduced in rats that have been depleted of insulin with the diabetogenic agent streptozotocin (STZ). In vitro studies suggest that hypoinsulinemia may regulate the actions of AMPH by inhibiting the insulin downstream effectors phosphotidylinositol 3-kinase (PI3K) and protein kinase B (PKB, or Akt), which we have previously shown are able to fine-tune DAT cell-surface expression. Here, we demonstrate that striatal Akt function, as well as DAT cell-surface expression, are significantly reduced by STZ. In addition, our data show that the release of DA, determined by high-speed chronoamperometry (HSCA) in the striatum, in response to AMPH, is severely impaired in these insulin-deficient rats. Importantly, selective inhibition of PI3K with LY294002 within the striatum results in a profound reduction in the subsequent potential for AMPH to evoke DA efflux. Consistent with our biochemical and in vivo electrochemical data, findings from functional magnetic resonance imaging experiments reveal that the ability of AMPH to elicit positive blood oxygen level-dependent signal changes in the striatum is significantly blunted in STZ-treated rats. Finally, local infusion of insulin into the striatum of STZ-treated animals significantly recovers the ability of AMPH to stimulate DA release as measured by high-speed chronoamperometry. The present studies establish that PI3K signaling regulates the neurochemical actions of AMPH-like psychomotor stimulants. These data suggest that insulin signaling pathways may represent a novel mechanism for regulating DA transmission, one which may be targeted for the treatment of AMPH abuse and potentially other dopaminergic disorders.",
author = "Williams, {Jason M.} and Owens, {W. Anthony} and Turner, {Gregory H.} and Christine Saunders and Concetta Dipace and Blakely, {Randy D.} and France, {Charles P} and Gore, {John C.} and Daws, {Lynette C} and Avison, {Malcolm J.} and Aurelio Galli",
year = "2007",
month = "10",
doi = "10.1371/journal.pbio.0050274",
language = "English (US)",
volume = "5",
pages = "2369--2378",
journal = "PLoS Biology",
issn = "1544-9173",
publisher = "Public Library of Science",
number = "10",

}

TY - JOUR

T1 - Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine

AU - Williams, Jason M.

AU - Owens, W. Anthony

AU - Turner, Gregory H.

AU - Saunders, Christine

AU - Dipace, Concetta

AU - Blakely, Randy D.

AU - France, Charles P

AU - Gore, John C.

AU - Daws, Lynette C

AU - Avison, Malcolm J.

AU - Galli, Aurelio

PY - 2007/10

Y1 - 2007/10

N2 - The behavioral effects of psychomotor stimulants such as amphetamine (AMPH) arise from their ability to elicit increases in extracellular dopamine (DA). These AMPH-induced increases are achieved by DA transporter (DAT)-mediated transmitter efflux. Recently, we have shown that AMPH self-administration is reduced in rats that have been depleted of insulin with the diabetogenic agent streptozotocin (STZ). In vitro studies suggest that hypoinsulinemia may regulate the actions of AMPH by inhibiting the insulin downstream effectors phosphotidylinositol 3-kinase (PI3K) and protein kinase B (PKB, or Akt), which we have previously shown are able to fine-tune DAT cell-surface expression. Here, we demonstrate that striatal Akt function, as well as DAT cell-surface expression, are significantly reduced by STZ. In addition, our data show that the release of DA, determined by high-speed chronoamperometry (HSCA) in the striatum, in response to AMPH, is severely impaired in these insulin-deficient rats. Importantly, selective inhibition of PI3K with LY294002 within the striatum results in a profound reduction in the subsequent potential for AMPH to evoke DA efflux. Consistent with our biochemical and in vivo electrochemical data, findings from functional magnetic resonance imaging experiments reveal that the ability of AMPH to elicit positive blood oxygen level-dependent signal changes in the striatum is significantly blunted in STZ-treated rats. Finally, local infusion of insulin into the striatum of STZ-treated animals significantly recovers the ability of AMPH to stimulate DA release as measured by high-speed chronoamperometry. The present studies establish that PI3K signaling regulates the neurochemical actions of AMPH-like psychomotor stimulants. These data suggest that insulin signaling pathways may represent a novel mechanism for regulating DA transmission, one which may be targeted for the treatment of AMPH abuse and potentially other dopaminergic disorders.

AB - The behavioral effects of psychomotor stimulants such as amphetamine (AMPH) arise from their ability to elicit increases in extracellular dopamine (DA). These AMPH-induced increases are achieved by DA transporter (DAT)-mediated transmitter efflux. Recently, we have shown that AMPH self-administration is reduced in rats that have been depleted of insulin with the diabetogenic agent streptozotocin (STZ). In vitro studies suggest that hypoinsulinemia may regulate the actions of AMPH by inhibiting the insulin downstream effectors phosphotidylinositol 3-kinase (PI3K) and protein kinase B (PKB, or Akt), which we have previously shown are able to fine-tune DAT cell-surface expression. Here, we demonstrate that striatal Akt function, as well as DAT cell-surface expression, are significantly reduced by STZ. In addition, our data show that the release of DA, determined by high-speed chronoamperometry (HSCA) in the striatum, in response to AMPH, is severely impaired in these insulin-deficient rats. Importantly, selective inhibition of PI3K with LY294002 within the striatum results in a profound reduction in the subsequent potential for AMPH to evoke DA efflux. Consistent with our biochemical and in vivo electrochemical data, findings from functional magnetic resonance imaging experiments reveal that the ability of AMPH to elicit positive blood oxygen level-dependent signal changes in the striatum is significantly blunted in STZ-treated rats. Finally, local infusion of insulin into the striatum of STZ-treated animals significantly recovers the ability of AMPH to stimulate DA release as measured by high-speed chronoamperometry. The present studies establish that PI3K signaling regulates the neurochemical actions of AMPH-like psychomotor stimulants. These data suggest that insulin signaling pathways may represent a novel mechanism for regulating DA transmission, one which may be targeted for the treatment of AMPH abuse and potentially other dopaminergic disorders.

UR - http://www.scopus.com/inward/record.url?scp=35648964732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35648964732&partnerID=8YFLogxK

U2 - 10.1371/journal.pbio.0050274

DO - 10.1371/journal.pbio.0050274

M3 - Article

VL - 5

SP - 2369

EP - 2378

JO - PLoS Biology

JF - PLoS Biology

SN - 1544-9173

IS - 10

ER -